Your browser doesn't support javascript.
loading
Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192].
Conforti, Fabio; Gronchi, Alessandro; Penel, Nicholas; Jones, Robin L; Broto, Javier M; Sala, Isabella; Bagnardi, Vincenzo; Napolitano, Andrea; Pala, Laura; Pennacchioli, Elisabetta; Catania, Chiara; Queirolo, Paola; Grigani, Giovanni; Merlini, Alessandra; Stacchiotti, Silvia; Comandone, Alessandro; Vincenzi, Bruno; Quagliuolo, Vittorio; Bertuzzi, Alexia; Boglione, Antonella; Palassini, Elena; Baldi, Giacomo G; Blay, Jean-Yves; Ryckewaert, Thomas; Toulmonde, Maud; Italiano, Antoine; Le Cesne, Axel; Ray-Coquard, Isabelle; Cruz, Josefina; Hernández-León, Carmen N; Trufero, Javier M; da Silva Moura, David; Muñiz, Nadia H; De Pas, Tommaso.
Afiliação
  • Conforti F; Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: fabio.conforti@ieo.it.
  • Gronchi A; Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Penel N; Lille University and Centre Oscar Lambret, Lille, France.
  • Jones RL; Sarcoma Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
  • Broto JM; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain; Medical Oncology Department, Hospital Fundación Jimenez Diaz University Hospital, Madrid, Spain; General de Villalba University Hospital, Madrid, 28400, Spain; Autonomous University of Madrid, Madrid, Spain.
  • Sala I; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
  • Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
  • Napolitano A; Sarcoma Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
  • Pala L; Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Pennacchioli E; Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Catania C; Division of Thoracic Oncology, European Institute of Oncology, Milan, Italy.
  • Queirolo P; Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
  • Grigani G; Candiolo Cancer Institute, FPO-IRCCS, Turin, Candiolo, 10060, Italy.
  • Merlini A; Candiolo Cancer Institute, FPO-IRCCS, Turin, Candiolo, 10060, Italy; Department of Oncology, University of Turin, Turin, Italy.
  • Stacchiotti S; Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Comandone A; Medical Oncology Unit, Ospedale Humanitas Gradenigo, Turin, Italy.
  • Vincenzi B; Medical Oncology Department, University Campus Bio-Medico, 00128 Rome, Italy.
  • Quagliuolo V; Department of Surgery, Istituto Clinico Humanitas, Rozzano, Italy.
  • Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
  • Boglione A; Medical Oncology Unit, Ospedale Humanitas Gradenigo, Turin, Italy.
  • Palassini E; Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Baldi GG; "Sandro Pitigliani'' Medical Oncology Department, Hospital of Prato, Prato, Italy.
  • Blay JY; Centre Léon Bérard & University Cl. Bernard Lyon I, EURACAN, LYRICAN, Lyon, France.
  • Ryckewaert T; Lille University and Centre Oscar Lambret, Lille, France.
  • Toulmonde M; Department of Medicine, Institut Bergonié, Bordeaux, Nouvelle-Aquitaine, France.
  • Italiano A; Department of Medicine, Institut Bergonié, Bordeaux, Nouvelle-Aquitaine, France.
  • Le Cesne A; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Ray-Coquard I; Centre Leon Bérard, Hesper Lab, EA 7425, Université Claude Bernard Lyon Est, Lyon, France.
  • Cruz J; Oncology Department, University Hospital of Canary Islands, Canary Islands, Spain.
  • Hernández-León CN; Pathology Department, University Hospital of Canary Islands, Canary Islands, Spain.
  • Trufero JM; Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
  • da Silva Moura D; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain; Autonomous University of Madrid, Madrid, Spain.
  • Muñiz NH; Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD), Madrid, Spain; Medical Oncology Department, Hospital Fundación Jimenez Diaz University Hospital, Madrid, Spain; General de Villalba University Hospital, Madrid, 28400, Spain; Autonomous University of Madrid, Madrid, Spain.
  • De Pas T; Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy.
Eur J Cancer ; 184: 197-198, 2023 May.
Article em En | MEDLINE | ID: mdl-36907702
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article